SubHero Banner
Text

April 2025

Core topics in this month’s edition include:

  • Imaavy™ (nipocalimab-aahu) – New orphan drug approval
  • Anoro Ellipta® (umeclidinium/vilanterol) – First-time authorized brand alternative
  • AvKare – Recall of ophthalmic solutions

Download